NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer

ABSTRACT: The main objective of the trial is to document the safety of NGR-hTNF administered at low and high doses in combination with a standard oxaliplatin based regimen in patients with metastatic colorectal cancer not amenable to any clinical improvement by current standard treatments

DISEASE(S): Colon Cancer,Patients With Metastatic Colorectal Cancer,Colorectal Cancer Metastatic,Colonic Neoplasms

PROVIDER: 2055168 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR